Global Consumer Healthcare

Consumer Healthcare Comprehensive Study by Type (OTC Pharmaceuticals, Dietary Supplements, Herbal Products), Distribution Channel (E-Commerce, Retail Stores, Convenience Stores, Pharmacy Stores, Supermarkets & Hypermarkets, Specialty Stores, Others), Price Range (Budget, Premium) Players and Region - Global Market Outlook to 2028

Consumer Healthcare Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 7.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Consumer Healthcare
Consumer healthcare is an industry-coined term which is centered around empowering individuals to self-manage their health. This was traditionally achieved through over-the-counter medications and the consumer-health care movement was largely led by the pharmaceutical companies. A heavily regulated sector, healthcare is one of the few industries that has so far largely evaded the wave of digital disruption that many other consumer-facing verticals such as media and. For the average care-seekers, the healthcare experience has remained largely the same as it was ten years ago. A new market of consumer-focused healthcare products is emerging to occupy the space between consumer goods and pharmaceuticals-and becoming a battleground that giants in both industries are gearing up to dominate. Consumer healthcare consists of over-the-counter drugs that directly sold to customers without any prescription from a healthcare professional. Today, consumers want solutions that allow them to take charge of their own health, and to be an informed stakeholder in their health decisions. Consumers want better, easier, self-serve ways to manage and improve their health and they are getting it with an increasing range of health management options as a result of easier and less expensive access to health information and products. This growth presents significant opportunities for manufacturers, retailers, and other stakeholders in the industry.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Billion)
CAGR7.3%


The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Consumer Healthcare market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Procter & Gamble (P&G) (United States), Pfizer (United States), Johnson & Johnson (United States), Novartis International AG (Switzerland), GlaxoSmithKline (United Kingdom), Sanofi (France), Abbott Laboratories (United States), Teva Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany) and Perrigo Company plc (Ireland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Haleon plc (United Kingdom), Merck (United States), Sun Pharmaceuticals Ltd. (India), Glenmark Pharmaceuticals Ltd. (India) and Piramal Enterprises Ltd. (India).

Segmentation Overview
AMA Research has segmented the market of Global Consumer Healthcare market by Type (OTC Pharmaceuticals, Dietary Supplements and Herbal Products) and Region.



On the basis of geography, the market of Consumer Healthcare has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Distribution Channel, the sub-segment i.e. E-Commerce will boost the Consumer Healthcare market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Price Range, the sub-segment i.e. Budget will boost the Consumer Healthcare market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Digital Platforms Provide Health Care Services

Market Growth Drivers:
Rising Demand for Self-Medication and Growing Demands of Sports Nutrition Products

Challenges:
Government Rules and Regulation are anticipated to Challenge the Market

Restraints:
Stiff Competition between the Major Players in term of Discounts

Opportunities:
Proliferation Usage of Smartphones and Social Media Reach Leads to Grow the Healthcare Products Market

Market Leaders and their expansionary development strategies
In October 2023, Bayer and Sanofi entered into the partnership for consumer healthcare businesses. This partnership combines Bayer's OTC brands like Aleve and Claritin with Sanofi's Allegra and Zantac, creating a new leader in the global allergy and cold care market.
In September 2023, Bio Oil launched their product Dry Skin Gel which appears to be a promising option for those seeking a fragrance-free, hydrating solution for dry and sensitive skin. With its combination of nourishing oils and hyaluronic acid, it aims to deliver deep moisture and comfort while being gentle enough for even the most delicate skin.
The over-the-counter (OTC) medicine industry is regulated by several government agencies, including the U.S. Food and Drug Administration, the U.S. Federal Trade Commission, and the U.S. Consumer Product Safety Commission.

Key Target Audience
Consumer Healthcare Products Manufacturers, Consumer Healthcare Products Traders, End-Use Market Participants of Different Segments of Consumer Healthcare Products, Government and Research Organizations, R&D Institutions and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • OTC Pharmaceuticals
  • Dietary Supplements
  • Herbal Products
By Distribution Channel
  • E-Commerce
  • Retail Stores
  • Convenience Stores
  • Pharmacy Stores
  • Supermarkets & Hypermarkets
  • Specialty Stores
  • Others

By Price Range
  • Budget
  • Premium

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Demand for Self-Medication
      • 3.2.2. Growing Demands of Sports Nutrition Products
    • 3.3. Market Challenges
      • 3.3.1. Government Rules and Regulation are anticipated to Challenge the Market
    • 3.4. Market Trends
      • 3.4.1. Digital Platforms Provide Health Care Services
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Consumer Healthcare, by Type, Distribution Channel, Price Range and Region (value and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Consumer Healthcare (Value)
      • 5.2.1. Global Consumer Healthcare by: Type (Value)
        • 5.2.1.1. OTC Pharmaceuticals
        • 5.2.1.2. Dietary Supplements
        • 5.2.1.3. Herbal Products
      • 5.2.2. Global Consumer Healthcare by: Distribution Channel (Value)
        • 5.2.2.1. E-Commerce
        • 5.2.2.2. Retail Stores
        • 5.2.2.3. Convenience Stores
        • 5.2.2.4. Pharmacy Stores
        • 5.2.2.5. Supermarkets & Hypermarkets
        • 5.2.2.6. Specialty Stores
        • 5.2.2.7. Others
      • 5.2.3. Global Consumer Healthcare by: Price Range (Value)
        • 5.2.3.1. Budget
        • 5.2.3.2. Premium
      • 5.2.4. Global Consumer Healthcare Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Consumer Healthcare (Price)
      • 5.3.1. Global Consumer Healthcare by: Type (Price)
  • 6. Consumer Healthcare: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Procter & Gamble (P&G) (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Johnson & Johnson (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Novartis International AG (Switzerland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. GlaxoSmithKline (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Sanofi (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Abbott Laboratories (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Bayer AG (Germany)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Perrigo Company plc (Ireland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Consumer Healthcare Sale, by Type, Distribution Channel, Price Range and Region (value and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Consumer Healthcare (Value)
      • 7.2.1. Global Consumer Healthcare by: Type (Value)
        • 7.2.1.1. OTC Pharmaceuticals
        • 7.2.1.2. Dietary Supplements
        • 7.2.1.3. Herbal Products
      • 7.2.2. Global Consumer Healthcare by: Distribution Channel (Value)
        • 7.2.2.1. E-Commerce
        • 7.2.2.2. Retail Stores
        • 7.2.2.3. Convenience Stores
        • 7.2.2.4. Pharmacy Stores
        • 7.2.2.5. Supermarkets & Hypermarkets
        • 7.2.2.6. Specialty Stores
        • 7.2.2.7. Others
      • 7.2.3. Global Consumer Healthcare by: Price Range (Value)
        • 7.2.3.1. Budget
        • 7.2.3.2. Premium
      • 7.2.4. Global Consumer Healthcare Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Consumer Healthcare (Price)
      • 7.3.1. Global Consumer Healthcare by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Consumer Healthcare: by Type(USD Billion)
  • Table 2. Consumer Healthcare OTC Pharmaceuticals , by Region USD Billion (2017-2022)
  • Table 3. Consumer Healthcare Dietary Supplements , by Region USD Billion (2017-2022)
  • Table 4. Consumer Healthcare Herbal Products , by Region USD Billion (2017-2022)
  • Table 5. Consumer Healthcare: by Distribution Channel(USD Billion)
  • Table 6. Consumer Healthcare E-Commerce , by Region USD Billion (2017-2022)
  • Table 7. Consumer Healthcare Retail Stores , by Region USD Billion (2017-2022)
  • Table 8. Consumer Healthcare Convenience Stores , by Region USD Billion (2017-2022)
  • Table 9. Consumer Healthcare Pharmacy Stores , by Region USD Billion (2017-2022)
  • Table 10. Consumer Healthcare Supermarkets & Hypermarkets , by Region USD Billion (2017-2022)
  • Table 11. Consumer Healthcare Specialty Stores , by Region USD Billion (2017-2022)
  • Table 12. Consumer Healthcare Others , by Region USD Billion (2017-2022)
  • Table 13. Consumer Healthcare: by Price Range(USD Billion)
  • Table 14. Consumer Healthcare Budget , by Region USD Billion (2017-2022)
  • Table 15. Consumer Healthcare Premium , by Region USD Billion (2017-2022)
  • Table 16. South America Consumer Healthcare, by Country USD Billion (2017-2022)
  • Table 17. South America Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 18. South America Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 19. South America Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 20. Brazil Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 21. Brazil Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 22. Brazil Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 23. Argentina Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 24. Argentina Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 25. Argentina Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 26. Rest of South America Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 27. Rest of South America Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 28. Rest of South America Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 29. Asia Pacific Consumer Healthcare, by Country USD Billion (2017-2022)
  • Table 30. Asia Pacific Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 31. Asia Pacific Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 32. Asia Pacific Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 33. China Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 34. China Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 35. China Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 36. Japan Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 37. Japan Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 38. Japan Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 39. India Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 40. India Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 41. India Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 42. South Korea Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 43. South Korea Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 44. South Korea Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 45. Taiwan Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 46. Taiwan Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 47. Taiwan Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 48. Australia Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 49. Australia Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 50. Australia Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 51. Rest of Asia-Pacific Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 52. Rest of Asia-Pacific Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 53. Rest of Asia-Pacific Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 54. Europe Consumer Healthcare, by Country USD Billion (2017-2022)
  • Table 55. Europe Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 56. Europe Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 57. Europe Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 58. Germany Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 59. Germany Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 60. Germany Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 61. France Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 62. France Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 63. France Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 64. Italy Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 65. Italy Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 66. Italy Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 67. United Kingdom Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 68. United Kingdom Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 69. United Kingdom Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 70. Netherlands Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 71. Netherlands Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 72. Netherlands Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 73. Rest of Europe Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 74. Rest of Europe Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 75. Rest of Europe Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 76. MEA Consumer Healthcare, by Country USD Billion (2017-2022)
  • Table 77. MEA Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 78. MEA Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 79. MEA Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 80. Middle East Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 81. Middle East Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 82. Middle East Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 83. Africa Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 84. Africa Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 85. Africa Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 86. North America Consumer Healthcare, by Country USD Billion (2017-2022)
  • Table 87. North America Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 88. North America Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 89. North America Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 90. United States Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 91. United States Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 92. United States Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 93. Canada Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 94. Canada Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 95. Canada Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 96. Mexico Consumer Healthcare, by Type USD Billion (2017-2022)
  • Table 97. Mexico Consumer Healthcare, by Distribution Channel USD Billion (2017-2022)
  • Table 98. Mexico Consumer Healthcare, by Price Range USD Billion (2017-2022)
  • Table 99. Consumer Healthcare: by Type(USD/Units)
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Consumer Healthcare: by Type(USD Billion)
  • Table 111. Consumer Healthcare OTC Pharmaceuticals , by Region USD Billion (2023-2028)
  • Table 112. Consumer Healthcare Dietary Supplements , by Region USD Billion (2023-2028)
  • Table 113. Consumer Healthcare Herbal Products , by Region USD Billion (2023-2028)
  • Table 114. Consumer Healthcare: by Distribution Channel(USD Billion)
  • Table 115. Consumer Healthcare E-Commerce , by Region USD Billion (2023-2028)
  • Table 116. Consumer Healthcare Retail Stores , by Region USD Billion (2023-2028)
  • Table 117. Consumer Healthcare Convenience Stores , by Region USD Billion (2023-2028)
  • Table 118. Consumer Healthcare Pharmacy Stores , by Region USD Billion (2023-2028)
  • Table 119. Consumer Healthcare Supermarkets & Hypermarkets , by Region USD Billion (2023-2028)
  • Table 120. Consumer Healthcare Specialty Stores , by Region USD Billion (2023-2028)
  • Table 121. Consumer Healthcare Others , by Region USD Billion (2023-2028)
  • Table 122. Consumer Healthcare: by Price Range(USD Billion)
  • Table 123. Consumer Healthcare Budget , by Region USD Billion (2023-2028)
  • Table 124. Consumer Healthcare Premium , by Region USD Billion (2023-2028)
  • Table 125. South America Consumer Healthcare, by Country USD Billion (2023-2028)
  • Table 126. South America Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 127. South America Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 128. South America Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 129. Brazil Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 130. Brazil Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 131. Brazil Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 132. Argentina Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 133. Argentina Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 134. Argentina Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 135. Rest of South America Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 136. Rest of South America Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 137. Rest of South America Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 138. Asia Pacific Consumer Healthcare, by Country USD Billion (2023-2028)
  • Table 139. Asia Pacific Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 140. Asia Pacific Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 141. Asia Pacific Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 142. China Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 143. China Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 144. China Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 145. Japan Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 146. Japan Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 147. Japan Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 148. India Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 149. India Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 150. India Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 151. South Korea Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 152. South Korea Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 153. South Korea Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 154. Taiwan Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 155. Taiwan Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 156. Taiwan Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 157. Australia Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 158. Australia Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 159. Australia Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 160. Rest of Asia-Pacific Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 161. Rest of Asia-Pacific Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 162. Rest of Asia-Pacific Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 163. Europe Consumer Healthcare, by Country USD Billion (2023-2028)
  • Table 164. Europe Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 165. Europe Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 166. Europe Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 167. Germany Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 168. Germany Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 169. Germany Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 170. France Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 171. France Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 172. France Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 173. Italy Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 174. Italy Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 175. Italy Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 176. United Kingdom Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 177. United Kingdom Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 178. United Kingdom Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 179. Netherlands Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 180. Netherlands Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 181. Netherlands Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 182. Rest of Europe Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 183. Rest of Europe Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 184. Rest of Europe Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 185. MEA Consumer Healthcare, by Country USD Billion (2023-2028)
  • Table 186. MEA Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 187. MEA Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 188. MEA Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 189. Middle East Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 190. Middle East Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 191. Middle East Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 192. Africa Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 193. Africa Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 194. Africa Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 195. North America Consumer Healthcare, by Country USD Billion (2023-2028)
  • Table 196. North America Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 197. North America Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 198. North America Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 199. United States Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 200. United States Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 201. United States Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 202. Canada Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 203. Canada Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 204. Canada Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 205. Mexico Consumer Healthcare, by Type USD Billion (2023-2028)
  • Table 206. Mexico Consumer Healthcare, by Distribution Channel USD Billion (2023-2028)
  • Table 207. Mexico Consumer Healthcare, by Price Range USD Billion (2023-2028)
  • Table 208. Consumer Healthcare: by Type(USD/Units)
  • Table 209. Research Programs/Design for This Report
  • Table 210. Key Data Information from Secondary Sources
  • Table 211. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Consumer Healthcare: by Type USD Billion (2017-2022)
  • Figure 5. Global Consumer Healthcare: by Distribution Channel USD Billion (2017-2022)
  • Figure 6. Global Consumer Healthcare: by Price Range USD Billion (2017-2022)
  • Figure 7. South America Consumer Healthcare Share (%), by Country
  • Figure 8. Asia Pacific Consumer Healthcare Share (%), by Country
  • Figure 9. Europe Consumer Healthcare Share (%), by Country
  • Figure 10. MEA Consumer Healthcare Share (%), by Country
  • Figure 11. North America Consumer Healthcare Share (%), by Country
  • Figure 12. Global Consumer Healthcare: by Type USD/Units (2017-2022)
  • Figure 13. Global Consumer Healthcare share by Players 2022 (%)
  • Figure 14. Global Consumer Healthcare share by Players (Top 3) 2022(%)
  • Figure 15. Global Consumer Healthcare share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Procter & Gamble (P&G) (United States) Revenue, Net Income and Gross profit
  • Figure 18. Procter & Gamble (P&G) (United States) Revenue: by Geography 2022
  • Figure 19. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 20. Pfizer (United States) Revenue: by Geography 2022
  • Figure 21. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 22. Johnson & Johnson (United States) Revenue: by Geography 2022
  • Figure 23. Novartis International AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 24. Novartis International AG (Switzerland) Revenue: by Geography 2022
  • Figure 25. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 26. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2022
  • Figure 27. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 28. Sanofi (France) Revenue: by Geography 2022
  • Figure 29. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 30. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 31. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 32. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2022
  • Figure 33. Bayer AG (Germany) Revenue, Net Income and Gross profit
  • Figure 34. Bayer AG (Germany) Revenue: by Geography 2022
  • Figure 35. Perrigo Company plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 36. Perrigo Company plc (Ireland) Revenue: by Geography 2022
  • Figure 37. Global Consumer Healthcare: by Type USD Billion (2023-2028)
  • Figure 38. Global Consumer Healthcare: by Distribution Channel USD Billion (2023-2028)
  • Figure 39. Global Consumer Healthcare: by Price Range USD Billion (2023-2028)
  • Figure 40. South America Consumer Healthcare Share (%), by Country
  • Figure 41. Asia Pacific Consumer Healthcare Share (%), by Country
  • Figure 42. Europe Consumer Healthcare Share (%), by Country
  • Figure 43. MEA Consumer Healthcare Share (%), by Country
  • Figure 44. North America Consumer Healthcare Share (%), by Country
  • Figure 45. Global Consumer Healthcare: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • Procter & Gamble (P&G) (United States)
  • Pfizer (United States)
  • Johnson & Johnson (United States)
  • Novartis International AG (Switzerland)
  • GlaxoSmithKline (United Kingdom)
  • Sanofi (France)
  • Abbott Laboratories (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Bayer AG (Germany)
  • Perrigo Company plc (Ireland)
Additional players considered in the study are as follows:
Haleon plc (United Kingdom) , Merck (United States) , Sun Pharmaceuticals Ltd. (India) , Glenmark Pharmaceuticals Ltd. (India) , Piramal Enterprises Ltd. (India)
Select User Access Type

Key Highlights of Report


Jan 2024 234 Pages 86 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Consumer Healthcare Quantitative research analysis
Global Consumer Healthcare Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Procter & Gamble (P&G) (United States), Pfizer (United States), Johnson & Johnson (United States), Novartis International AG (Switzerland), GlaxoSmithKline (United Kingdom), Sanofi (France), Abbott Laboratories (United States), Teva Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany) and Perrigo Company plc (Ireland) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Digital Platforms Provide Health Care Services" is seen as one of major influencing trends for Consumer Healthcare Market during projected period 2022-2028.
The Consumer Healthcare market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.
Analysts at AMA estimates Consumer Healthcare Market to reach USD646.0 Billion by 2028.

Know More About Global Consumer Healthcare Report?

Have a Query? Click Here

Other Related Reports

Foam Dressings Comprehensive Study by Type (Foam Dressings With Adhesive Border, Foam Dressings With Silicone Border), Application (Hospitals, Clinics, Homecare, Other), Pore Size (Small, Medium, Lar...
$ 3500
Pet Health Comprehensive Study by Application (Household, Pet Shop, Veterinary, Others), Product (Pet Food, Pet Accessories, Pet Grooming, Pet Healthcare), Product Distribution Channel (Offline, Onli...
$ 3450
Medical Specialty Bags Comprehensive Study by Type (Ostomy Collection Bags, Intravenous (IV) Fluid bags, Continuous Ambulatory Peritoneal Dialysis (CAPD) Bags, Resuscitation Bags, Urinary Collection ...
$ 3750
Oral Hygiene Comprehensive Study by Type (Brushing, Flossing, Rinsing), Application (Men, Women, Child, Old Age People), Distribution Channel (Consumer Stores, Retail Pharmacies, Online Stores, Denta...
$ 3750
Clean Room Materials Comprehensive Study by Type (Cleanroom Apparels, Cleaning Product, Cleanroom Stationary, Wipers, Gloves, Adhesive Mats, Others), Application (Electronics, Pharmaceutical and Biol...
$ 3450
Hair Transplant Comprehensive Study by Type (Surgical, Non-Surgical), Techniques (Follicular Unit Extraction (FUE), Follicular Hair Transplantation (FUT) , Direct Hair Implantation (DHI)), Service Pr...
$ 3650